Related references
Note: Only part of the references are listed.cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms
Marco Cosentino et al.
IMMUNOLOGY (2018)
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis
Bryan Nicol et al.
JOURNAL OF AUTOIMMUNITY (2018)
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFN gamma Dependent
Giulia Nizzoli et al.
JOURNAL OF CROHNS & COLITIS (2018)
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+Th1/Th2/T17 and Treg in drug-naive and drugtreated patients
Natasa Kustrimovic et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease
Gabriela Mercado et al.
NEUROBIOLOGY OF DISEASE (2018)
Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
Francisco Osorio-Barrios et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study
Servaas Buijs et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)
Dopaminergic stimulation of Myeloid antigen-Presenting cells attenuates signal Transducer and activator of Transcription 3-activation Favouring the Development of experimental autoimmune encephalomyelitis
Carolina Prado et al.
FRONTIERS IN IMMUNOLOGY (2018)
The genetic landscape of Parkinson's disease
A. Lunati et al.
REVUE NEUROLOGIQUE (2018)
Emerging Treatment Approaches for Parkinson's Disease
Thomas B. Stoker et al.
FRONTIERS IN NEUROSCIENCE (2018)
Neurodegeneration and the ordered assembly of α-synuclein
Maria Grazia Spillantini et al.
CELL AND TISSUE RESEARCH (2018)
Epidemiology of Parkinson's Disease-East Versus West
Masoom M. Abbas et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2018)
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice
Vicente Lieberknecht et al.
MOLECULAR NEUROBIOLOGY (2017)
A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation
Stefan H. Oehlers et al.
FEBS JOURNAL (2017)
Dopaminergic Regulation of Innate Immunity: a Review
Monica Pinoli et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
TFH-derived dopamine accelerates productive synapses in germinal centres
Ilenia Papa et al.
NATURE (2017)
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi et al.
NATURE (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease
Daniela Elgueta et al.
NEUROPHARMACOLOGY (2017)
Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease
Dong Hyuk Seo et al.
SCIENTIFIC REPORTS (2017)
Mend Your Fences The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease
Eva Martini et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases
M. Levite
ACTA PHYSIOLOGICA (2016)
Parkinson's disease: Autoimmunity and neuroinflammation
Armando De Virgilio et al.
AUTOIMMUNITY REVIEWS (2016)
L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia
Luz M. Suarez et al.
CEREBRAL CORTEX (2016)
Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors
A. Sagarduy et al.
EXPERIMENTAL NEUROLOGY (2016)
Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury
Shaoping Hou et al.
EXPERIMENTAL NEUROLOGY (2016)
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis
Alice Laroni et al.
JOURNAL OF AUTOIMMUNITY (2016)
Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1-and Th17-Mediated Immunity
Francisco Contreras et al.
JOURNAL OF IMMUNOLOGY (2016)
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis
Marco Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis
Mikhail Melnikov et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology
Josefine R. Christiansen et al.
JOURNAL OF NEUROINFLAMMATION (2016)
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio et al.
LANCET NEUROLOGY (2016)
Astrocyte scar formation aids central nervous system axon regeneration
Mark A. Anderson et al.
NATURE (2016)
In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease
Sherise L. Simms et al.
NEUROPHARMACOLOGY (2016)
Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice
Maria Grazia Zizzo et al.
PEDIATRIC RESEARCH (2016)
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
Catharina C. Gross et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Epidemiology of Parkinson's disease
A. Elbaz et al.
REVUE NEUROLOGIQUE (2016)
Cost of Illness of Multiple Sclerosis - A Systematic Review
Olivia Ernstsson et al.
PLOS ONE (2016)
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Yiqing Yan et al.
CELL (2015)
Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease
Ganna Tolstanova et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects
Marco Cosentino et al.
HUMAN IMMUNOLOGY (2015)
Dopamine receptor DR2 expression in B cells is negatively correlated with disease activity in rheumatoid arthritis patients
L. Wei et al.
IMMUNOBIOLOGY (2015)
Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats
Marjan Popovic et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+T-cells
Hugo Gonzalez et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Berberine is a dopamine D1-and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses
Masaald Kawano et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Dopamine receptors D3 and D5 regulate CD4+ T-cell activation and differentiation by modulating ERK activation and cAMP production
Dafne Franz et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Dopaminergic modulation of locomotor network activity in the neonatal mouse spinal cord
Simon A. Sharples et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation
Nicola Gagliani et al.
NATURE (2015)
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy
Rui Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Aline Verstraeten et al.
TRENDS IN GENETICS (2015)
The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders
Ekaterina Dobryakova et al.
FRONTIERS IN NEUROLOGY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Experimental Models of Inflammatory Bowel Diseases
Patricia Kiesler et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Innate and adaptive immunity in inflammatory bowel disease
Alessandra Geremia et al.
AUTOIMMUNITY REVIEWS (2014)
L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2-Expressing Projection Neurons in Dyskinetic Mice
Luz M. Suarez et al.
BIOLOGICAL PSYCHIATRY (2014)
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
Marios Politis et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
Hugo Gonzalez et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases
Hugo Gonzalez et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease
Maxwell B. Santana et al.
NEURON (2014)
Dopamine: a parallel pathway for the modulation of spinal locomotor networks
Simon A. Sharples et al.
FRONTIERS IN NEURAL CIRCUITS (2014)
Chronic Spinal Cord Electrical Stimulation Protects Against 6-hydroxydopamine Lesions
Amol P. Yadav et al.
SCIENTIFIC REPORTS (2014)
The dopaminergic system in autoimmune diseases
Rodrigo Pacheco et al.
FRONTIERS IN IMMUNOLOGY (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease
Hiroya Utsumi et al.
INTERNAL MEDICINE (2013)
The burden of inflammatory bowel disease in Europe
Johan Burisch et al.
JOURNAL OF CROHNS & COLITIS (2013)
Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease
Hugo Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2013)
The current and projected economic burden of Parkinson's disease in the United States
Stacey L. Kowal et al.
MOVEMENT DISORDERS (2013)
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin
Wei Shao et al.
NATURE (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
Modulation of T-cell Mediated Immunity by Dopamine Receptor D5
Carolina Prado et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2013)
Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice
Yasunari Asano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
Scott M. Hayter et al.
AUTOIMMUNITY REVIEWS (2012)
Neurotoxin-Induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling
Senthil Selvaraj et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
Carolina Prado et al.
JOURNAL OF IMMUNOLOGY (2012)
Normal Midbrain Dopaminergic Neuron Development and Function in miR-133b Mutant Mice
Mary P. Heyer et al.
JOURNAL OF NEUROSCIENCE (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
Penelope J. Hallett et al.
NEUROBIOLOGY OF DISEASE (2012)
Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy
Marco Cosentino et al.
NEUROIMMUNOMODULATION (2012)
L-745,870 Reduces L-DOPA-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
Philippe Huot et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Case Report Showing That a Woman with Ulcerative Colitis Refractory to Standard Therapy Responded Well to the Sympathomimetic Amine Dextroamphetamine Sulfate
Jerome H. Check et al.
INFLAMMATORY BOWEL DISEASES (2011)
Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production
Ting Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Hypofunction of the sympathetic nervous system is an etiologic factor for a wide variety of chronic treatment-refractory pathologic disorders which all respond to therapy with sympathomimetic amines
J. H. Check et al.
MEDICAL HYPOTHESES (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Mitochondrial dysfunction in Parkinson's disease
Konstanze F. Winklhofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Novel Highly Effective Medical Treatment of Severe Treatment: Refractory Crohn's Disease Using Sympathomimetic Amines: Case Report
Jerome H. Check et al.
INFLAMMATORY BOWEL DISEASES (2010)
Fatigue and Cognition in Patients with Relapsing Multiple Sclerosis Treated with Interferon Beta
Maria Melanson et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Evolving paradigms in the pathogenesis of IBD
Lloyd Mayer
JOURNAL OF GASTROENTEROLOGY (2010)
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and F-18-FDOPA PET Outcomes
Yilong Ma et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Treatment of the nonmotor symptoms of Parkinson disease
Werner Poewe
NATURE REVIEWS NEUROLOGY (2010)
Regulatory Lymphocytes and Intestinal Inflammation
Ana Izcue et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
Filip Simunovic et al.
BRAIN (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis
Kazuhisa Nakano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis
Mauro Zaffaroni et al.
EXPERIMENTAL NEUROLOGY (2008)
STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury
Julia E. Herrmann et al.
JOURNAL OF NEUROSCIENCE (2008)
Familial aggregation of Parkinson's disease: A meta-analysis
Evan L. Thacker et al.
MOVEMENT DISORDERS (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The role of dendritic cells in the development of acute dextran sulfate sodium colitis
Bradford E. Berndt et al.
JOURNAL OF IMMUNOLOGY (2007)
A microRNA feedback circuit in midbrain dopamine neurons
Jongpil Kim et al.
SCIENCE (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
John D. Rioux et al.
NATURE GENETICS (2007)
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
Marco Cosentino et al.
BLOOD (2007)
The immune response in inflammatory bowel disease
Steven J. Brown et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment
F. Magro et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
A population-based case control study of potential risk factors for IBD
Charles N. Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
The primary defect in experimental ileitis originates from a nonhematopoietic source
TS Olson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor:: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice
ZS Li et al.
JOURNAL OF NEUROSCIENCE (2006)
Sympathetic overactivity in active ulcerative colitis: effects of clonidine
R Furlan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients:: Effects of IFN-β
M Giorelli et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Pathogenesis of levodopa-induced dyskinesia:: focus on D1 and D3 dopamine receptors
C Guigoni et al.
PARKINSONISM & RELATED DISORDERS (2005)
Depression in multiple sclerosis: a review
RJ Siegert et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-γ upon L-DOPA uptake
F Magro et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2004)
Review article:: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
E Bézard et al.
NATURE MEDICINE (2003)
Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study
F McKenna et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease
F Magro et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Treatment of depression is associated with suppression of nonspecific and antigen-specific TH1 responses in multiple sclerosis
DC Mohr et al.
ARCHIVES OF NEUROLOGY (2001)
Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system
CA Mastronardi et al.
NEUROIMMUNOMODULATION (2001)
Structure and function of dopamine receptors
D Vallone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Share Paper
